Match!
Winfried März
Medical University of Graz
EndocrinologyCardiologyCoronary artery diseaseDiabetes mellitusMedicine
1,041Publications
90H-index
39.7kCitations
What is this?
Publications 960
Newest
#1Sonia ShahH-Index: 36
#2Albert HenryH-Index: 1
Last. Mark ChaffinH-Index: 12
view all 202 authors...
#1Marcus E. Kleber (Heidelberg University)H-Index: 51
#2Graciela Delgado (Heidelberg University)H-Index: 20
Last. Winfried März (Medical University of Graz)H-Index: 90
view all 3 authors...
1 CitationsSource
#1Ingrid GergeiH-Index: 2
#2Thorsten KälschH-Index: 13
Last. Anna-Isabelle KälschH-Index: 6
view all 5 authors...
BACKGROUND: The association of platelet and monocyte activity markers with long-term mortality was assessed in hemodialysis (HD) patients. METHODS: In 41 HD patients (25 male, 16 female), surface expression of CD40L and CD62P on platelets, tissue factor (TF) binding on monocytes, and platelet-monocyte aggregates were measured by flow cytometry. Plasma levels of MCP-1, IL-6, TNFalpha, and soluble CD40L were analyzed by enzyme linked immunosorbent assay. Cox proportional hazard regression analyses...
Source
#1Anna-Isabelle Kälsch (Heidelberg University)H-Index: 6
#2Hubert Scharnagl (Medical University of Graz)H-Index: 33
Last. Ernst Malle (Medical University of Graz)H-Index: 28
view all 9 authors...
Background The present study aimed to evaluate biomarkers representing low-grade systemic inflammation and their association with cardiovascular mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Source
#1M Berger (RWTH Aachen University)H-Index: 2
Last. Katharina Schuett (RWTH Aachen University)H-Index: 3
view all 8 authors...
Source
#1B. Genser (University of Würzburg)
#2Christoph Wanner (University of Würzburg)H-Index: 76
Last. Winfried März (Medical University of Graz)H-Index: 90
view all 3 authors...
AimsHaemodialysis patients have high cardiovascular disease risk. Although statins reduce this risk in chronic kidney disease, randomised trials in haemodialysis patients show no benefit. Post-hoc ...
Source
#1Boris BikbovH-Index: 38
Last. Marcela Agudelo-BoteroH-Index: 1
view all 222 authors...
Summary Background Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries. We estimated the global, regional, and national burden of CKD, as well as the burden of cardiovascular disease and gout attributable to impaired kidney function, for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. We use the term CKD to refer to the morbidity and...
2 CitationsSource
#1Graciela Delgado (Heidelberg University)H-Index: 20
#2Bernhard K. Krämer (Heidelberg University)H-Index: 47
Last. Alexander Lammert (Heidelberg University)H-Index: 10
view all 8 authors...
Source
#1Stephen Zewinger (Saarland University)H-Index: 11
#2Jochen Reiser (Rush University Medical Center)H-Index: 50
Last. Thimoteus Speer (Saarland University)H-Index: 15
view all 35 authors...
NLRP3-inflammasome-driven inflammation is involved in the pathogenesis of a variety of diseases. Identification of endogenous inflammasome activators is essential for the development of new anti-inflammatory treatment strategies. Here, we identified that apolipoprotein C3 (ApoC3) activates the NLRP3 inflammasome in human monocytes by inducing an alternative NLRP3 inflammasome via caspase-8 and dimerization of Toll-like receptors 2 and 4. Alternative inflammasome activation in human monocytes is ...
2 CitationsSource
Last. Hall Ma
view all 7 authors...
12345678910